The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)
Bangladesh · Delayed Price · Currency is BDT 297.20
-0.70 (-0.23%)
At close: Nov 4, 2026
DSE:IBNSINA Income Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 13,900 | 11,884 | 11,371 | 9,125 | 8,480 | |
Revenue Growth | 16.97% | 4.51% | 24.61% | 7.61% | 14.96% |
Cost of Revenue | 8,147 | 7,084 | 6,839 | 5,254 | 4,914 |
Gross Profit | 5,753 | 4,800 | 4,532 | 3,871 | 3,566 |
Selling, General & Admin | 4,646 | 3,898 | 3,617 | 3,051 | 2,745 |
Operating Expenses | 4,646 | 3,898 | 3,617 | 3,051 | 2,745 |
Operating Income | 1,107 | 902.17 | 914.57 | 819.81 | 821.16 |
Interest Expense | -127.84 | -87.4 | -53.58 | -44.43 | -47.33 |
Interest & Investment Income | - | 3.08 | 4.13 | 2.37 | 3.33 |
Earnings From Equity Investments | - | - | - | - | -1.29 |
Currency Exchange Gain (Loss) | - | 1.22 | 7.26 | 11.15 | -2.83 |
Other Non Operating Income (Expenses) | 35.23 | 20.55 | 21.95 | 13.59 | 17.22 |
EBT Excluding Unusual Items | 1,015 | 839.61 | 894.34 | 802.5 | 790.27 |
Gain (Loss) on Sale of Investments | - | - | - | - | 9.6 |
Gain (Loss) on Sale of Assets | - | 0.36 | 0.36 | 2.23 | - |
Pretax Income | 1,015 | 839.97 | 894.7 | 804.73 | 799.86 |
Income Tax Expense | 221.65 | 206.72 | 223.35 | 198.92 | 194.19 |
Earnings From Continuing Operations | 792.93 | 633.26 | 671.35 | 605.81 | 605.67 |
Minority Interest in Earnings | 1.71 | -0.07 | -0.83 | -0.39 | 0.19 |
Net Income | 794.63 | 633.19 | 670.52 | 605.42 | 605.87 |
Net Income to Common | 794.63 | 633.19 | 670.52 | 605.42 | 605.87 |
Net Income Growth | 25.50% | -5.57% | 10.75% | -0.07% | 23.87% |
Shares Outstanding (Basic) | 31 | 31 | 31 | 31 | 31 |
Shares Outstanding (Diluted) | 31 | 31 | 31 | 31 | 31 |
Shares Change | - | - | - | - | - |
EPS (Basic) | 25.43 | 20.27 | 21.46 | 19.38 | 19.39 |
EPS (Diluted) | 25.43 | 20.27 | 21.46 | 19.38 | 19.39 |
EPS Growth | 25.50% | -5.57% | 10.75% | -0.07% | 23.87% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -1,848 | -257.82 | -556.9 | 472.99 | 53.4 |
Free Cash Flow Per Share | -59.13 | -8.25 | -17.82 | 15.14 | 1.71 |
Dividend Per Share | - | 6.400 | 6.300 | 6.000 | 6.000 |
Dividend Growth | - | 1.59% | 5.00% | 0% | 27.66% |
Gross Margin | 41.39% | 40.39% | 39.85% | 42.42% | 42.05% |
Operating Margin | 7.96% | 7.59% | 8.04% | 8.98% | 9.68% |
Profit Margin | 5.72% | 5.33% | 5.90% | 6.63% | 7.14% |
Free Cash Flow Margin | -13.29% | -2.17% | -4.90% | 5.18% | 0.63% |
EBITDA | 1,311 | 1,088 | 1,093 | 1,558 | 1,021 |
EBITDA Margin | 9.43% | 9.15% | 9.61% | 17.07% | 12.04% |
D&A For EBITDA | 204.07 | 185.55 | 178.12 | 738.18 | 199.57 |
EBIT | 1,107 | 902.17 | 914.57 | 819.81 | 821.16 |
EBIT Margin | 7.96% | 7.59% | 8.04% | 8.98% | 9.68% |
Effective Tax Rate | 21.85% | 24.61% | 24.96% | 24.72% | 24.28% |
Advertising Expenses | - | 65.83 | 63.23 | 51.87 | 47.72 |